Phase 3 trial in Peru for 2 Sinopharm inactivated virus vaccines suspended to investigate possible Guillain-Barre in a participant (which is a serious neurological event known to be a rare vaccine effect).
Guillain-Barre syndrome is a rare and non-contagious disorder which affects the movement of the arms and legs.
The health ministry said the event is “under investigation to determine if it is related to the vaccine or if there is another explanation.”
https://www.reuters.com/article/health-coronavirus-peru-vaccine-idUSL1N2IS09J
Leave a Reply